Deal Snapshot
CRYOLIFE CLOSES ACQUISITION OF JOTEC TO EXPAND PRODUCT PORTFOLIO IN STENT GRAFT MARKET
Wednesday 06 December 2017

Georgia, US-based medical device and implatable tissues provider CryoLife, Inc. (NYSE: CRY), a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications medical device developer, has closed the acquisition of Germany based surgical grafts developer Jotec AG, to strengthen geographic footprint and expand offerings in the stent graft market, the company said.
This deal was announced in October. Under terms of the definitive agreement, CryoLife acquired Jotec for an upfront payment of USD 225m, consisting of 75% in cash and 25% in CryoLife common stock issued to Jotec's shareholders.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 06/12/2017
Target: Jotec AG
Country: Germany
Deal Size: 225m (USD)
Sector: Healthcare
Type: Corporate acquisition
Financing: Cash and Stock
Status: Closed
Vendor:
Buyer: CryoLife, Inc
Buyer Advisor: Vinson and,  Elkins 
Comment:


Options